Involvement of the Akt signaling pathway in ER‑α36/GRP94‑mediated signaling in gastric cancer

Fu,Zhengqi; Zhen,Hongyan; Zou,Feng; Wang,Xuming; Chen,Ying; Liu,Lijiang

doi:10.3892/ol.2014.2514

Involvement of the Akt signaling pathway in ER‑α36/GRP94‑mediated signaling in gastric cancer

Authors:
- Zhengqi Fu
- Hongyan Zhen
- Feng Zou
- Xuming Wang
- Ying Chen
- Lijiang Liu
View Affiliations

Affiliations: Department of Pathology and Pathophysiology, School of Medicine, Jianghan University, Wuhan, Hubei 430056, P.R. China, Jiangda Pathology Institute, Jianghan University, Wuhan, Hubei 430056, P.R. China
Published online on: September 9, 2014 https://doi.org/10.3892/ol.2014.2514
Pages: 2077-2080

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glucose‑regulated protein 94 (GRP94) has been implicated in the promotion of tumor proliferation and metastasis. Previous studies have found that GRP94 is involved in the malignant growth of gastric carcinoma cells through estrogen receptor‑α36 (ER‑α36)‑mediated estrogen signaling, but the underlying mechanism remains unclear. In the present study, we examined the expression levels of GRP94 and ER-α36 in tumor specimens from gastric cancer patients by immunohistochemistry, and found that both GRP94 and ER-α36 were highly expressed in the cytoplasms of gastric carcinoma cells.Furthermore, treatment with 17β‑estradiol at a concentration of 10−12 M for 24 h increased the expression levels of GRP94 and ER‑α36, and the phosphorylation levels of Akt at the Ser473 site (Ser473‑Akt). In established SGC7901 gastric cancer cells with knockdown of ER‑α36 expression, the levels of GRP94 and Ser473‑Akt expression were significantly reduced. Thus, the Akt signaling pathway is a potentially important signaling pathway in ER‑α36‑GRP94‑mediated gastric carcinogenesis.

View Figures

View References

1	Li J and Lee AS: Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med. 6:45–54. 2006.
2	Srivastava PK: Therapeutic cancer vaccines. Curr Opin Immunol. 18:201–205. 2006.
3	Fu Z, Deng H, Wang X, et al: Involvement of ER-alpha36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression. Histopathology. 63:325–333. 2013.
4	Sheu ML, Liu SH and Lan KH: Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth. PLoS One. 2:e10962007.
5	Lambert R, Guilloux A, Oshima A, et al: Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer. 97:811–818. 2002.
6	Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477. 2009.
7	Chandanos E, Lindblad M, Rubio CA, et al: Tamoxifen exposure in relation to gastric adenocarcinoma development. Eur J Cancer. 44:1007–1014. 2008.
8	Rutqvist LE, Johansson H, Signomklao T, et al: Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst. 87:645–651. 1995.
9	Deng H, Huang X, Fan J, et al: A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis. Oncol Rep. 24:171–176. 2010.
10	Wang X, Deng H, Zou F, et al: ER-alpha36-mediated gastric cancer cell proliferation via the c-Src pathway. Oncol Lett. 6:329–335. 2013.
11	Wang Z, Zhang X, Shen P, et al: A variant of estrogen receptor-α, hER-α36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA. 103:9063–9068. 2006.
12	Fu ZQ, Yang Y, Song J, et al: LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3beta in vivo and in vitro. J Alzheimers Dis. 21:1107–1117. 2010.
13	Deng H, Zhen H, Fu Z, et al: The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer. Oncol Lett. 3:193–199. 2012.
14	Kang L, Zhang X, Xie Y, et al: Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol. 24:709–721. 2010.
15	Suntharalingam A, Abisambra JF, O’Leary JC III, et al: Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism. J Biol Chem. 287:40661–40669. 2012.
16	Zheng HC, Takahashi H, Li XH, et al: Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum Pathol. 39:1042–1049. 2008.
17	Jones PF, Jakubowicz T, Pitossi FJ, Maurer F and Hemmings BA: Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA. 88:4171–4175. 1991.
18	Garcia GE, Nicole A, Bhaskaran S, et al: Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract. Neoplasia. 8:523–533. 2006.
19	Gottlob K, Majewski N, Kennedy S, et al: Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15:1406–1418. 2001.
20	Ang KL, Shi DL, Keong WW and Epstein RJ: Upregulated Akt signaling adjacent to gastric cancers: implications for screening and chemoprevention. Cancer Lett. 225:53–59. 2005.
21	Oki E, Baba H, Tokunaga E, et al: Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int J Cancer. 117:376–380. 2005.
22	Yu HG, Ai YW, Yu LL, et al: Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer. 122:433–443. 2008.
23	Guo RX, Wei LH, Tu Z, et al: 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. J Steroid Biochem Mol Biol. 99:9–18. 2006.
24	Stoica GE, Franke TF, Wellstein A, et al: Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Mol Endocrinol. 17:818–830. 2003.
25	Park S, Song J, Joe CO and Shin I: Akt stabilizes estrogen receptor alpha with the concomitant reduction in its transcriptional activity. Cell Signal. 20:1368–1374. 2008.